Conavi Medical Corp.
CNVIF
Rang in Aktien
#33165
Conavi Medical Corp. is a medical technology firm that specializes in... Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Aktienkurs
$0.0919
Marktkapitalisierung
$7.84M
Veränderung (1 Tag)
-7.73%
Veränderung (1 Jahr)
-88.76%
Land
CA
Handel Conavi Medical Corp. (CNVIF)
Kategorie
Healthcare
P/S-Verhältnis für Conavi Medical Corp. (CNVIF)
P/S-Verhältnis zum October 2026 TTM: 0.77
Laut den neuesten Finanzberichten und dem Aktienkurs von Conavi Medical Corp. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0.77. Am Ende des Jahres 2022 lag das P/S-Verhältnis bei 0.00.
P/S-Verlauf für Conavi Medical Corp. von 2007 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 0.77 | -91.99% |
| 2023 | 9.67 | 0.00% |
| 2022 | 0.00 | -100.00% |
| 2021 | 85.60 | -39.99% |
| 2020 | 142.65 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | 0.00% |
| 2012 | 0.00 | 0.00% |
| 2011 | 0.00 | 0.00% |
| 2010 | 0.00 | 0.00% |
| 2009 | 0.00 | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 3.82 | 393.65% |
US
|
|
| 2.78 | 259.43% |
IE
|
|
| 4.18 | 439.33% |
US
|
|
| 2.97 | 283.38% |
US
|
|
| - | - |
DE
|
